Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;11(2):115-117.
doi: 10.1016/S2213-2600(22)00394-0. Epub 2022 Oct 7.

The elusive goal of COVID-19 vaccine immunity

Laith J Abu-Raddad  1 , Hiam Chemaitelly  2
Affiliations
Comment

The elusive goal of COVID-19 vaccine immunity

Laith J Abu-Raddad et al. Lancet Respir Med. 2023 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Tartof SY, Slezak JM, Puzniak L, et al. Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00354-X. published online Oct 7. - DOI - PMC - PubMed
    1. Butt AA, Dargham SR, Coyle P, et al. COVID-19 disease severity in persons infected with omicron BA.1 and BA.2 sublineages and association with vaccination status. JAMA Intern Med. 2022 doi: 10.1001/jamainternmed.2022.3351. published online Aug 22. - DOI - PMC - PubMed
    1. Stowe J, Andrews N, Kirsebom F, Ramsay M, Bernal JL. Effectiveness of COVID-19 vaccines against omicron and delta hospitalisation: test negative case-control study. medRxiv. 2022 doi: 10.1101/2022.04.01.22273281. published online April 1. (preprint). - DOI - PMC - PubMed
    1. Feikin DR, Abu-Raddad LJ, Andrews N, et al. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization. Vaccine. 2022;40:3516–3527. - PMC - PubMed
    1. WHO Living guidance for clinical management of COVID-19. Nov 23, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2

Substances